《IJID,6月12日,Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-06-14
  • Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak
    Author links open overlay panelAuthors: LuisPenarrubiaaMariaRuizaRobertoPorcoaSonia N.RaobMartíJuanola-FalgaronaaDavideManisserocMartaLópez-FontanalsaJosepParejaa
    Show more
    https://doi.org/10.1016/j.ijid.2020.06.027

    Abstract
    Objectives
    In this study, five SARS-CoV-2 PCR assay panels were evaluated against the accumulated genetic variability of the virus to assess the effect on sensitivity of the individual assays.

    Design or methods
    As of week 21, 2020, the complete set of available SARS-CoV-2 genomes from GISAID and GenBank databases were used in this study. SARS-CoV-2 primer sequences from publicly available panels (WHO, CDC, NMDC, and HKU) and QIAstat-Dx were included in the alignment, and accumulated genetic variability affecting any oligonucleotide annealing was annotated.

  • 原文来源:https://www.sciencedirect.com/science/article/pii/S120197122030463X
相关报告
  • 《6月12日_RT-PCR多次检测SARS-CoV-2可减少由基因组变异引起的检测敏感性丢失》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-06-14
    • 信息名称:RT-PCR多次检测SARS-CoV-2可减少由基因组变异引起的检测敏感性丢失 1.时间:2020年6月12日 2.机构或团队:西班牙STAT-Dx公司、美国QIAGEN公司 3.事件概要: 西班牙STAT-Dx公司等机构在International Journal of Infectious Diseases发表论文“Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak”。 文章针对病毒累积的遗传变异对5个SARS-CoV-2 PCR检测面板进行了评估,以评估对单个检测的敏感性。在2020年第21周,文章使用了来自GISAID和GenBank数据库的完整的SARS-CoV-2基因组,使用了来自公开的平台(WHO、CDC、NMDC和HKU)和QIAstat-Dx的SARS-CoV-2引物序列进行比对,注释了影响寡核苷酸退火的累积遗传变异。分析结果显示,共有11,627个基因组(34.38%)包含单个突变,影响PCR试验的退火,8,773(25.94%)基因组的变异被认为是高风险,而另外2,854(8.43%)基因组表现为低频率的单突变,预计不会对敏感性产生影响。在QIAstat-Dx面板中,99.11%的基因组匹配了100%的寡核苷酸覆盖率,并且在体外测试了关键变异,证实敏感性没有损失。 4.附件: 原文链接:https://www.sciencedirect.com/science/article/pii/S120197122030463X
  • 《Nature,6月16日,Optimization of primer sets and detection protocols for SARS-CoV-2 of coronavirus disease 2019 (COVID-19) using PCR and real-time PCR》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-06-17
    • Optimization of primer sets and detection protocols for SARS-CoV-2 of coronavirus disease 2019 (COVID-19) using PCR and real-time PCR Myungsun Park, Joungha Won, Byung Yoon Choi & C. Justin Lee Experimental & Molecular Medicine (2020) Abstract SARS-CoV-2 is very contagious and has rapidly spread globally. Due to various symptomatic and asymptomatic cases and the possibility of asymptomatic transmission, there is a pressing need for a fast and sensitive detection protocol to diagnose asymptomatic people. Various SARS-CoV-2 diagnostic kits are already available from many companies and national health agencies. However, publicly available information on these diagnostic kits is lacking. In response to the growing need and the lack of information, we developed and made available a low-cost, easy-access, real-time PCR-based protocol for the early detection of the virus in a previous study. During the development of the detection protocol, we found that unoptimized primer sets could inadvertently show false-positive results, raising the possibility that commercially available diagnostic kits might also contain primer sets that produce false-positive results. Here, we provide three-step guidelines for the design and optimization of specific primer sets. The three steps include (1) the selection of primer sets for target genes (RdRP, N, E, and S) in the genome of interest (SARS-CoV-2), (2) the in silico validation of primer and amplicon sequences, and (3) the optimization of PCR conditions (i.e., primer concentrations and annealing temperatures) for specific hybridization between the primers and target genes, and the elimination of spurious primer dimers. Furthermore, we have expanded the previously developed real-time PCR-based protocol to more conventional PCR-based protocols and applied a multiplex PCR-based protocol that allows the simultaneous testing of primer sets for RdRP, N, E, and S all in one reaction. Our newly optimized protocol should be helpful for the large-scale, high-fidelity screening of asymptomatic people, even without any high-specification equipment, for the further prevention of transmission, and to achieve early intervention and treatment for the rapidly propagating virus.